- Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence
-
Chan SN, Low EN, Raja Ali R, Mokhtar NM
- KMID: 2417649
- Intest Res.
- 2018 Jul;16(3):374-383.
- doi: 10.5217/ir.2018.16.3.374
Inflammatory bowel disease (IBD), which comprises of Crohn's disease and ulcerative colitis, is an idiopathic relapsing and remitting disease in which the interplay of different environment, microbial, immunological and genetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?
-
Shafiee NH, Manaf ZA, Mokhtar NM, Raja Ali RA
- KMID: 2515476
- Intest Res.
- 2021 Apr;19(2):171-185.
- doi: 10.5217/ir.2020.00035
Current treatment for inflammatory bowel disease (IBD) includes the application of anti-inflammatory agents for the induction and remission of IBD. However, prolonged use of anti-inflammatory agents can exert adverse effects... -
- CITED
-
- Close
- SHARE
-
- Close
- An assessment of dietary intake, food avoidance and food beliefs in patients with ulcerative colitis of different disease status
-
Shafiee NH, Manaf ZA, Mokhtar NM, Raja Ali RA
- KMID: 2508577
- Intest Res.
- 2020 Oct;18(4):447-458.
- doi: 10.5217/ir.2019.00042
Background/Aims: Ulcerative colitis (UC) is a chronic, relapsing and remitting inflammation of the gastrointestinal tract. Little is known about the link between dietary intake, food avoidance, and beliefs among UC... -
- CITED
-
- Close
- SHARE
-
- Close
- An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia
-
Shafiee NH, Razalli NH, Mokhtar NM, Tan E, Ali RAR
- KMID: 2525079
- Intest Res.
- 2022 Jan;20(1):124-133.
- doi: 10.5217/ir.2020.00050
Background/Aims: Substantial proportions of patients with constipation-predominant irritable bowel syndrome (IBS-C) linked their symptoms with particular intake of foods. However, there is lack of current data regarding the intake among... -
- CITED
-
- Close
- SHARE
-
- Close
